NMCAX
Price
$19.71
Change
-$0.21 (-1.05%)
Updated
Aug 29 closing price
Net Assets
715.09M
RRMGX
Price
$90.21
Change
-$0.43 (-0.47%)
Updated
Aug 29 closing price
Net Assets
27.31B
Interact to see
Advertisement

NMCAX vs RRMGX

Header iconNMCAX vs RRMGX Comparison
Open Charts NMCAX vs RRMGXBanner chart's image
Voya MidCap Opportunities A
Price$19.71
Change-$0.21 (-1.05%)
VolumeN/A
Net Assets715.09M
T. Rowe Price Mid-Cap Growth R
Price$90.21
Change-$0.43 (-0.47%)
VolumeN/A
Net Assets27.31B
NMCAX vs RRMGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NMCAX vs. RRMGX commentary
Sep 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMCAX is a Hold and RRMGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 27.3B vs. NMCAX (715M). NMCAX (0.00) and RRMGX (0.00) have matching dividends . NMCAX was incepted earlier than RRMGX: NMCAX (27 years) vs RRMGX (23 years). RRMGX (1.29) and NMCAX (1.25) have similar cost to investors . NMCAX is a more actively managed with annual turnover of: 87.00 vs. RRMGX (22.60). NMCAX has a lower initial minimum investment than RRMGX: NMCAX (1000) vs RRMGX (2500). NMCAX annual gain was more profitable for investors over the last year : 7.06 vs. RRMGX (-6.32). RRMGX return over 5 years is better than : -5.01 vs. NMCAX (-15.04).
NMCAXRRMGXNMCAX / RRMGX
Total Expense Ratio1.251.2997%
Annual Report Gross Expense Ratio1.251.2997%
Fund Existence27 years23 years-
Gain YTD8.2372.605316%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets715M27.3B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year7.06-6.32-112%
Returns for 3 years28.408.06352%
Returns for 5 years-15.04-5.01300%
Returns for 10 years-10.2122.67-45%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVM10.431.12
+12.03%
Cel-Sci Corp
NNNN45.043.57
+8.60%
Anbio Biotechnology
PNW89.360.04
+0.04%
Pinnacle West Capital Corp
UOKA2.56N/A
N/A
MDJM Ltd
SLDB5.48-0.14
-2.49%
Solid Biosciences